Literature DB >> 29720902

Translational Research in Familial Colorectal Cancer Syndromes.

Molly M Ford1.   

Abstract

Growing knowledge of inherited colorectal cancer syndromes has led to better surveillance and better care of this subset of patients. The most well-known entities, including Lynch syndrome and familial adenomatous polyposis, are continually being studied and with the advent of more sophisticated genetic testing, additional genetic discoveries have been made in the field of inherited cancer. This article will summarize many of the updates to both the familiar and perhaps less familiar syndromes that can lead to inherited or early-onset colorectal cancer.

Entities:  

Keywords:  FAP; Lynch syndrome; POLE/POLD1; familial colorectal cancer; serrated polyposis

Year:  2018        PMID: 29720902      PMCID: PMC5929886          DOI: 10.1055/s-0037-1602236

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  36 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 2.  Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance.

Authors:  James E East; Michael Vieth; Douglas K Rex
Journal:  Gut       Date:  2015-03-06       Impact factor: 23.059

3.  Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.

Authors:  Doua Bakry; Melyssa Aronson; Carol Durno; Hala Rimawi; Roula Farah; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Shay Ben-Shachar; Matthew Mistry; Shlomi Constantini; Rina Dvir; Ibrahim Qaddoumi; Steven Gallinger; Jordan Lerner-Ellis; Aaron Pollett; Derek Stephens; Steve Kelies; Elizabeth Chao; David Malkin; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  Eur J Cancer       Date:  2014-01-15       Impact factor: 9.162

4.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

5.  Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).

Authors:  H F A Vasen; Z Ghorbanoghli; F Bourdeaut; O Cabaret; O Caron; A Duval; N Entz-Werle; Y Goldberg; D Ilencikova; C P Kratz; N Lavoine; J Loeffen; F H Menko; M Muleris; G Sebille; C Colas; B Burkhardt; L Brugieres; K Wimmer
Journal:  J Med Genet       Date:  2014-02-20       Impact factor: 6.318

6.  Risk of cancer in cases of suspected lynch syndrome without germline mutation.

Authors:  María Rodríguez-Soler; Lucía Pérez-Carbonell; Carla Guarinos; Pedro Zapater; Adela Castillejo; Victor M Barberá; Miriam Juárez; Xavier Bessa; Rosa M Xicola; Juan Clofent; Luis Bujanda; Francesc Balaguer; Josep-Maria Reñé; Luisa de-Castro; José C Marín-Gabriel; Angel Lanas; Joaquín Cubiella; David Nicolás-Pérez; Alejandro Brea-Fernández; Sergi Castellví-Bel; Cristina Alenda; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Montserrat Andreu; Xavier Llor; José L Soto; Artemio Payá; Rodrigo Jover
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

Review 7.  Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

Authors:  John M Carethers; Elena M Stoffel
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening.

Authors:  Zaid M Abdelsattar; Sandra L Wong; Scott E Regenbogen; Diana M Jomaa; Karin M Hardiman; Samantha Hendren
Journal:  Cancer       Date:  2016-01-25       Impact factor: 6.860

9.  Colorectal cancer in young patients: is it a distinct clinical entity?

Authors:  Hadar Goldvaser; Ofer Purim; Yulia Kundel; Daniel Shepshelovich; Tzippy Shochat; Lital Shemesh-Bar; Aaron Sulkes; Baruch Brenner
Journal:  Int J Clin Oncol       Date:  2016-01-28       Impact factor: 3.402

Review 10.  POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.

Authors:  Fernando Bellido; Marta Pineda; Gemma Aiza; Rafael Valdés-Mas; Matilde Navarro; Diana A Puente; Tirso Pons; Sara González; Silvia Iglesias; Esther Darder; Virginia Piñol; José Luís Soto; Alfonso Valencia; Ignacio Blanco; Miguel Urioste; Joan Brunet; Conxi Lázaro; Gabriel Capellá; Xose S Puente; Laura Valle
Journal:  Genet Med       Date:  2015-07-02       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.